Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Fresenius Medical Care ( FMS – Research Report ), with a price target of $42.00 . The company’s shares closed
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on The Ensign Group (ENSG), with a price target of $48.00. The company's
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on The Ensign Group ( ENSG – Research Report ), with a price target of $48.00 . The company’s shares closed last M
RBC Capital analyst Frank Morgan maintained a Hold rating on DaVita (DVA) today and set a price target of $75.00. The company's shares closed last Monday
RBC Capital analyst Frank Morgan maintained a Hold rating on DaVita ( DVA – Research Report ) today and set a price target of $75.00 . The company’s shares closed last Monday at $77.20. According
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Encompass Health (EHC), with a price target of $84.00. The company's
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Encompass Health ( EHC – Research Report ), with a price target of $84.00 . The company’s shares closed last Mo
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Addus Homecare (ADUS), with a price target of $98.00. The company's
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Addus Homecare ( ADUS – Research Report ), with a price target of $98.00 . The company’s shares closed last Fri
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on LHC Group (LHCG), with a price target of $173.00. The company's
RBC Capital analyst Frank Morgan maintained a Buy rating on Amedisys (AMED) today and set a price target of $218.00. The company's shares closed last
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Chemed (CHE) and Regeneron (REGN). Chemed (CHE) RBC Capital analyst
Genesis HealthCare (“Genesis”) (GEN), one of the largest post-acute care providers in the United States, today announced that its founder, Michael R. Walker passed away over the weekend after a lo
Today we are going to look at Genesis Healthcare, Inc. (NYSE:GEN) to see whether it might be an attractive investment...
Companies in the Services sector have received a lot of coverage today as analysts weigh in on WW Grainger (GWW), Alibaba (BABA) and Community Health
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE